查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1226701

维他命K2的全球市场:现状分析与预测(2022年～2028年)

Vitamin K2 Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球维他命K2的市场规模，在预测期间内预计稳定成长约25％。维他命缺乏症的患者层的扩大，含维他命K2的产品的需求高涨，关节炎的病例增加等牵引市场成长。

本报告提供全球维他命K2市场相关调查分析，市场概要，各市场区隔、各地区的市场分析，市场成长的影响因素，市场趋势，竞争情形，主要企业简介等彙整资讯。

目录

第1章 市场简介

第2章 调查手法与前提

第3章 市场概要

第4章 摘要整理

第5章 COVID-19对维他命K2市场的影响

第6章 维他命K2市场收益(2020年～2028年)

第7章 市场洞察:各来源

  • 天然
  • 合成

第8章 市场洞察:各产品

  • MK-4
  • MK-7
  • 其他

第9章 市场洞察:各用途

  • 医药品
  • 营养补充品和食品
  • 其他

第10章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第11章 维他命K2市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第12章 维他命K2市场机会

第13章 维他命K2市场趋势

第14章 需求与供给分析

  • 需求分析
  • 供给分析

第15章 价值链分析

第16章 竞争模式

  • 竞争情形
    • 波特的五力分析

第17章 公司概要

  • DSM
  • SEEBIO BIOTECH(SHANGHAI)CO., LTD.
  • Viridis BioPharma Pvt. Ltd.
  • Lesaffre
  • KYOWA HAKKO BIO CO,. LTD.
  • International Flavors & Fragrances Inc.
  • GeneFerm Biotechnology Co., Ltd.
  • DuPont
  • Kappa Bioscience
  • Vox Nutrition

第18章 免责声明

简介目录
Product Code: UMME211588

The vitamin K2 Market is expected to grow at a steady rate of around 25% during the forecast period. Vitamin K2 is naturally produced in human intestines by bacteria. The western diet is deficient in vitamin K2; hence pharmaceuticals and supplemental diets are required to provide vitamin K2. The market is expanding as a result of an expanding patient base with vitamin deficiencies, rising demand for products containing Vitamin K2, and rising cases of arthritis. For instance, according to the Centers for Disease Control and Prevention (CDC), around 1 in 4 US adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis.

Along with calcium and vitamin D, vitamin K2 may be an effective supplement for the treatment of osteoporosis that is toxic-free and comparable to bisphosphonate therapy. By reducing arterial calcification, it may also considerably reduce cardiovascular morbidity and mortality. In the cases of diabetes, cancer, and osteoarthritis, vitamin K2 appears promising. Although a dosage adjustment is necessary, the use of vitamin K during warfarin medication is safe and may help with INR (International Normalized Ratio) control.

Based on source, the market is segmented into natural and synthetic. Among them, synthetic category to witness higher CAGR during the forecast period. The high rate of production, an increase in vitamin deficiency disorders, increasing health awareness, and substantial economic expansion for nutritional supplements are the major factors for the growth of the vitamin K2 market.

On the basis of product, the market is categorized into MK-4, MK-7, and others. Among these, the MK-7 to hold a significant share in the market in 2020. This is mainly due to the growing usage of dietary supplements rising cases of coronary artery diseases because MK-7 based vitamin's reduces the risk of coronary artery diseases, and vitamin K2 as MK-7, improves bone density by making blood vessels softer and bones harder.

Based on application, the vitamin K2 market has been classified into pharmaceuticals, nutraceuticals & food, and others. The pharmaceuticals category is to witness a significant growth rate during the forecast period. This is mainly due to the changing food habits, changing lifestyle, health awareness, and standard of living. Also, the applications of vitamin K2 is useful in pharmaceutical industry focusing on dental, CVDs, and bone related deficiencies which will drive the market growth during the forecast period.

For a better understanding of the market adoption of the vitamin K2 industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the prevalence of effective medical facilities in nations like the United States and Canada, the rising use of herbal medicines, increasing healthcare expenditures, and the government's emphasis on health and wellness. Moreover, the inclination toward living a healthy life is leading to the growing consumption of supplements including vitamin K2 and the expansion of the food and beverage and cosmetic industries are the driving factors for the expansion of the regional market.

Some of the major players operating in the market include: DSM, SEEBIO BIOTECH (SHANGHAI) CO., LTD., Viridis BioPharma Pvt. Ltd., Lesaffre, KYOWA HAKKO BIO CO. LTD., International Flavors & Fragrances Inc., GeneFerm Biotechnology Co. Ltd., DuPont, Kappa Bioscience, Vox Nutrition

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Vitamin K2 Market
  • 2.2. Research Methodology of the Vitamin K2 Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE VITAMIN K2 MARKET

6 VITAMIN K2 MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SOURCE

  • 7.1. Natural
  • 7.2. Synthetic

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. MK-4
  • 8.2. MK-7
  • 8.3. Others

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Pharmaceuticals
  • 9.2. Nutraceuticals & Food
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 VITAMIN K2 MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 VITAMIN K2 MARKET OPPORTUNITIES

13 VITAMIN K2 MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. DSM
  • 17.2. SEEBIO BIOTECH (SHANGHAI) CO., LTD.
  • 17.3. Viridis BioPharma Pvt. Ltd.
  • 17.4. Lesaffre
  • 17.5. KYOWA HAKKO BIO CO., LTD.
  • 17.6. International Flavors & Fragrances Inc.
  • 17.7. GeneFerm Biotechnology Co., Ltd.
  • 17.8. DuPont
  • 17.9. Kappa Bioscience
  • 17.10. Vox Nutrition

18 DISCLAIMER